14-day Premium Trial Subscription Try For FreeTry Free
$1.86
+0.0500 (+2.76%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Mar 12, 2024 Buy 224 800 Brown Scott B. Employee Stock Option (Right to Buy)
Mar 12, 2024 Buy 518 300 Theuer Charles Employee Stock Option (Right to Buy)
Oct 20, 2023 Buy 3 500 Theuer Charles Common Stock
Apr 27, 2023 Buy 47 000 Theuer Charles Common Stock
Apr 26, 2023 Buy 3 999 Theuer Charles Common Stock
Apr 20, 2023 Buy 3 500 Brown Scott B. Common Stock
Apr 20, 2023 Buy 3 500 Theuer Charles Common Stock
Apr 19, 2023 Buy 18 000 Johnson-pratt Lisa Director Stock Option (Right to Buy)
Apr 19, 2023 Buy 18 000 Lam Carol C. Director Stock Option (Right to Buy)
Apr 19, 2023 Buy 18 000 Pelletier Saundra L Director Stock Option (Right to Buy)
Apr 19, 2023 Buy 18 000 Mattingly Martin A Director Stock Option (Right to Buy)
Apr 19, 2023 Buy 18 000 Worland Stephen T Director Stock Option (Right to Buy)
Apr 19, 2023 Buy 18 000 Larue William R Director Stock Option (Right to Buy)
Apr 19, 2023 Buy 18 000 Twiford J Rainer Director Stock Option (Right to Buy)
Mar 09, 2023 Buy 174 508 Opaleye Management Inc. Common Stock, par value $0.001 per share
Mar 01, 2023 Buy 4 800 Theuer Charles Common Stock
Feb 28, 2023 Buy 200 Theuer Charles Common Stock
Feb 01, 2023 Buy 99 000 Adams Bonne J. Employee Stock Option (Right to Buy)
Feb 01, 2023 Buy 0 Adams Bonne J. Common Stock
Feb 01, 2023 Buy 1 360 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 1 078 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 4 122 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 5 499 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 6 591 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 12 499 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 17 600 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 55 000 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 80 000 Adams Bonne J. Employee Stock Options (Right to Buy)
Feb 01, 2023 Buy 144 000 Brown Scott B. Employee Stock Option (Right to Buy)
Feb 01, 2023 Buy 332 000 Theuer Charles Employee Stock Option (Right to Buy)
Jan 18, 2023 Buy 6 800 Theuer Charles Common Stock
Dec 29, 2022 Buy 3 500 Brown Scott B. Common Stock
Dec 21, 2022 Sell 120 Larue William R Common Stock
Dec 14, 2022 Buy 140 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Dec 14, 2022 Buy 27 500 Opaleye Management Inc. Common Stock, par value $0.001 per share
Dec 14, 2022 Buy 23 000 Theuer Charles Common Stock
Dec 06, 2022 Buy 221 539 Opaleye Management Inc. Common Stock, par value $0.01 per share
Dec 06, 2022 Sell 1 539 Opaleye Management Inc. Common Stock, par value $0.01 per share
Dec 06, 2022 Sell 221 539 Opaleye Management Inc. Prefunded Warrants
Nov 18, 2022 Buy 13 900 Theuer Charles Common Stock
Nov 03, 2022 Buy 9 200 Theuer Charles Common Stock
Nov 02, 2022 Buy 6 000 Theuer Charles Common Stock
Oct 18, 2022 Buy 2 500 Opaleye Management Inc. Common Stock, par value $0.001 per share
Oct 18, 2022 Buy 10 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Oct 07, 2022 Buy 5 000 Theuer Charles Common Stock
Oct 03, 2022 Buy 5 000 Theuer Charles Common Stock
Sep 29, 2022 Buy 9 400 Opaleye Management Inc. Common Stock, par value $0.001 per share
Sep 27, 2022 Buy 1 700 Opaleye Management Inc. Common Stock, par value $0.001 per share
Sep 22, 2022 Buy 5 000 Theuer Charles Common Stock
Sep 22, 2022 Buy 3 411 Opaleye Management Inc. Common Stock, par value $0.001 per share
Sep 22, 2022 Buy 13 900 Opaleye Management Inc. Common Stock, par value $0.001 per share
Sep 20, 2022 Buy 10 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Sep 19, 2022 Buy 5 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Sep 12, 2022 Buy 2 500 Brown Scott B. Common Stock
Jul 26, 2022 Buy 2 254 Opaleye Management Inc. Common Stock, par value $0.001 per share
Jul 22, 2022 Buy 4 500 Theuer Charles Common Stock
Jul 15, 2022 Buy 11 826 Opaleye Management Inc. Common Stock, par value $0.001 per share
Jul 14, 2022 Buy 7 187 Opaleye Management Inc. Common Stock, par value $0.001 per share
Jul 12, 2022 Buy 3 000 Theuer Charles Common Stock
Jun 24, 2022 Buy 11 419 Opaleye Management Inc. Common Stock, par value $0.001 per share
Jun 21, 2022 Buy 841 989 Opaleye Management Inc. Common Stock, par value $0.001 per share
Jun 14, 2022 Buy 15 750 Twiford J Rainer Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Twiford J Rainer Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Worland Stephen T Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Worland Stephen T Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Larue William R Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Mattingly Martin A Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Mattingly Martin A Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Lam Carol C. Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Pelletier Saundra L Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Pelletier Saundra L Director Stock Option (Right to Buy)
Jun 14, 2022 Buy 15 750 Johnson-pratt Lisa Director Stock Option (Right to Buy)
May 10, 2022 Buy 8 500 Opaleye Management Inc. Common Stock, par value $0.001 per share
May 10, 2022 Buy 1 200 Opaleye Management Inc. Common Stock, par value $0.001 per share
May 09, 2022 Buy 10 000 Theuer Charles Common Stock
May 06, 2022 Buy 2 500 Theuer Charles Common Stock
Apr 29, 2022 Buy 5 000 Theuer Charles Common Stock
Apr 29, 2022 Buy 6 100 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 25, 2022 Buy 777 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 22, 2022 Buy 6 100 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 22, 2022 Buy 1 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 22, 2022 Buy 10 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 22, 2022 Buy 37 704 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 22, 2022 Buy 4 296 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 21, 2022 Buy 4 500 Theuer Charles Common Stock
Apr 14, 2022 Buy 2 696 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 13, 2022 Buy 10 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 13, 2022 Buy 5 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 13, 2022 Buy 2 345 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 12, 2022 Buy 13 098 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 11, 2022 Buy 6 463 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 11, 2022 Buy 5 000 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 11, 2022 Buy 2 637 Opaleye Management Inc. Common Stock, par value $0.001 per share
Apr 08, 2022 Buy 2 000 Theuer Charles Common Stock
Mar 30, 2022 Buy 4 000 Theuer Charles Common Stock
Mar 29, 2022 Buy 1 000 Brown Scott B. Common Stock
Mar 21, 2022 Buy 1 200 Theuer Charles Common Stock
Jan 28, 2022 Buy 265 000 Theuer Charles Employee Stock Option (Right to Buy)
Jan 28, 2022 Buy 80 000 Wiggins Mark C Employee Stock Option (Right to Buy)
Jan 28, 2022 Buy 80 000 Brown Scott B. Employee Stock Option (Right to Buy)
JSON CSV
INSIDER POWER
84.145
Last 100 transactions
Buy: 4 027 247 | Sell: 223 198 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 84.145.

In total, the insiders bought 4 027 247 and sold 223 198 TCON shares in the last 100 trades.

Click to get the best stock tips daily for free!

About TRACON Pharmaceuticals

TRACON Pharmaceuticals TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also... TCON Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT